Search

Your search keyword '"Tinea Versicolor"' showing total 76 results

Search Constraints

Start Over You searched for: Descriptor "Tinea Versicolor" Remove constraint Descriptor: "Tinea Versicolor" Journal mycoses Remove constraint Journal: mycoses
76 results on '"Tinea Versicolor"'

Search Results

1. Factors associated with pityriasis versicolor in a large national database.

2. Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015‐2020

3. Fungal diseases in children and adolescents in a referral centre in Bogota, Colombia.

4. Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial.

5. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.

6. The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study.

7. Influence of systemic corticotherapy on the triggering of pityriasis versicolor.

8. Expression of antimicrobial peptides and toll-like receptors is increased in tinea and pityriasis versicolor.

9. Malassezia yeast species isolated from Iranian patients with pityriasis versicolor in a prospective study.

10. The genetic epidemiology of tinea versicolor in China.

11. Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015-2020.

12. MGL_3741 gene contributes to pathogenicity of Malassezia globosa in pityriasis versicolor

13. Influence of systemic corticotherapy on the triggering of pityriasis versicolor

14. Coexistence of pityriasis versicolor and erythrasma.

15. Pityriasis versicolor on the groin mimicking erythrasma.

16. The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study

17. Identification ofMalasseziaspecies from pityriasis versicolor in Indonesia and its relationship with clinical characteristics

18. Vergleich der klinischen Wirksamkeit und Verträglichkeit von Oxiconazol nach 1 x täglicher Applikation mit der nach 2 x täglicher Applikation./Comparison of Clinical Efficacy and Tolerability of Oxiconazole, one Dose Versus two Doses Daily

19. Studies on Pityriasis Versicolor in Egypt

20. Malassezia Intertrigo, a New Clinical Entity

21. Clinical and Epidemiological Studies of Tinea Versicolor in Kuwait

22. Fungal infection as a cause of skin disease in the Eastern Province of Saudi Arabia: prevailing fungi and pattern of infection

23. Dermatophytoses in forestry workers and farmers

24. Identification of Malassezia species from Tunisian patients with pityriasis versicolor and normal subjects

25. Pityriasis versicolor during anti-TNF-α monoclonal antibody therapy: therapeutic considerations

26. Rapid reversal of hyperpigmentation in pityriasis versicolor upon short-term topical cycloserine application

27. Pityrosporum orbiculare in Children

28. Clinical Experience with Canesten-Cream*) (Bay b 5097) against Dermatophytes in Egypt

29. The Frequency of Pityrosporum Orbiculare as a Skin Commensal Among an Israeli Population

30. Topical Treatment of Dermatomycoses with Canesten®*) Cream, a New Antimycotic Compound

31. Syndrome of Carteaud and Gougerot -Case Report:Confluent and reticulate papillomatosis

32. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial

33. Pityrosporumyeasts - what's new?

34. Expression of antimicrobial peptides and toll-like receptors is increased in tinea and pityriasis versicolor

35. The epidemiology of pityriasis versicolor in Malawi, Africa

36. Coexistence of pityriasis versicolor and erythrasma. Fallbericht. Pityriasis versicolor vergesellschaftet mit Erythrasma

37. A double-blind, randomized comparative trial: flutrimazole 1% solution versus bifonazole 1% solution once daily in dermatomycoses

38. Pityriasis versicolor during anti-TNF-α monoclonal antibody therapy: therapeutic considerations

39. Malassezia yeast species isolated from Iranian patients with pityriasis versicolor in a prospective study

40. Childhood dermatomycoses study in Sfax Hospital, Tunisia

41. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study

42. Malassezia furfurcolonization of neonates in an intensive care unit

43. The genetic epidemiology of tinea versicolor in China

44. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor

45. Quantitative investigation on the distribution of Malassezia species on healthy human skin in Korea

46. [Missing granulocytic infiltrate in pityriasis versicolor--indication of specific anti-inflammatory activity of the pathogen?]

47. Phospholipase activity inMalassezia furfurpathogenic strains

48. Prevalence and causative agents of superficial mycoses in a textile factory in Adana, Turkey

49. Hydrolase activity of 150 Malassezia furfur isolates of different clinical origin

50. [Morphology of Malassezia-associated diseases]

Catalog

Books, media, physical & digital resources